Back
Monopar Therapeutics Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
MNPR
Monopar Therapeutics
Last Price:
$38.89
Seasonality Move:
-7.08%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.22 | Buy |
| 20-day SMA: | 35.93 | Buy |
| 50-day SMA: | 36.84 | Buy |
| 200-day SMA: | 19.47 | Buy |
| 8-day EMA: | 36.55 | Buy |
| 20-day EMA: | 35.63 | Buy |
| 50-day EMA: | 34.92 | Buy |
| 200-day EMA: | 23.59 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 57.1 | Buy |
| Chaikin Money Flow: | 2638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.98 - 40.08) | Buy |
| Bollinger Bands (100): | (23.95 - 40.87) | Buy |
Monopar Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.59 while MNPR 8-day simple moving average is 35.22, which is a Buy signal.
-
The stock price of MNPR is 39.59 while Monopar Therapeutics 20-day SMA is 35.93, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 36.84 while MNPR share price is 39.59, making it a Buy technically.
-
MNPR stock price is 39.59 and Monopar Therapeutics 200-day simple moving average is 19.47, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $39.59. The Score for MNPR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
242M
Price in USD:
39.59
Share Volume:
11.6K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
51
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 39.59 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.59 while MNPR 8-day exponential moving average is 36.55, which is a Buy signal.
-
The stock price of MNPR is 39.59 while Monopar Therapeutics 20-day EMA is 35.63, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 34.92 while MNPR share price is 39.59, making it a Buy technically.
-
MNPR stock price is 39.59 and Monopar Therapeutics 200-day simple moving average is 23.59, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 57.1, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (31.98 - 40.08), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (23.95 - 40.87), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.